1,559 results on '"Guazzoni, Giorgio"'
Search Results
2. Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection
3. Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
4. MP31-03 DECODING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY NAIVE PATIENTS: A MACHINE LEARNING APPROACH FROM A TERTIARY REFERRAL CENTER
5. PD13-12 DIAGNOSTIC PERFORMANCE OF MICROULTRASOUND AT CONFIRMATORY RECLASSIFICATION BIOPSY IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
6. MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL
7. MP49-15 EVALUATING THE ROLE OF PRI-MUS PROTOCOL IN IDENTIFYING CLINICALLY SIGNIFICANT PROSTATE CANCER: A HIGH-VOLUME EXPERIENCE ON MICROULTRASOUND
8. MP67-03 IMPACT OF NUMBER OF INNER AND OUTER RENORRAPHY STITCHES ON FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
9. MP35-10 LONG TERM FOLLOW UP AND RISK OF HIGH-GRADE RECURRENCE IN LOW-GRADE PTA BLADDER CANCER PATIENTS
10. MP74-08 [68GA]PSMA PET/CT VS. MPMRI IN PATIENTS WITH SUSPICION OF PROSTATE CANCER AND PREVIOUS NEGATIVE BIOPSY: RESULTS OF THE PROSPET-BX TRIAL
11. Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study
12. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience
13. Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study
14. Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis
15. Retrotrigonal muscular layer sling associated with total anatomical reconstruction in robot-assisted radical prostatectomy and early continence
16. Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
17. Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?
18. The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?
19. How I faced my prostate cancer: a molecular biologist’s perspective
20. Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study)
21. Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project
22. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer
23. Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non–muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project
24. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer
25. Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
26. Interim analyses from the PROSPET-BX trial: [ G8 Ga]PSMA PET/CT vs. mpMRI in patients with suspicion of prostate cancer and previous negative biopsy.
27. Role of Restaging Transurethral Resection for T1 Non–muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis
28. 68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study
29. Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes
30. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer
31. Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study
32. An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
33. Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
34. Diagnostic performance of microUltrasound at MRI‐guided confirmatory biopsy in patients under active surveillance for low‐risk prostate cancer
35. MP73-16 SUV VARIATION ON PSMA PET/CT CORRELATES WITH BIOCHEMICAL RESPONSE IN PATIENTS WITH PROSTATE CANCER UNDERGOING HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOCAL THERAPY
36. MP55-03 CORRELATION BETWEEN PSMA PET/CT DATA AND PATHOLOGICAL TUMOUR STAGING AND GRADING OF PROSTATE CANCER
37. MP55-19 MICRO-ULTRASOUND GUIDED PROSTATE BIOPSIES: EXPERIENCE FROM A HIGH-VOLUME CENTER
38. Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve non-muscle invasive bladder cancer (NMIBC).
39. Awareness of genetic risk for prostate cancer (PCa) in men from families with germline mutations in DNA-repair genes.
40. Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX)
41. Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index
42. Minimally Invasive Partial Nephrectomy Versus Laparoscopic Cryoablation for Patients Newly Diagnosed with a Single Small Renal Mass
43. Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
44. Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy
45. Indication for and Extension of Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: An Analysis of Five European Institutions
46. Long-Term Followup and Deterioration Rate of Anterior Substitution Urethroplasty
47. Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
48. Head-to-Head Comparison between High-Resolution Microultrasound Imaging and Multiparametric MRI in Detecting and Local Staging of Bladder Cancer: The BUS-MISS Protocol
49. Crioterapia e brachiterapia nel trattamento del carcinoma prostatico
50. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.